Hoth Therapeutics, Inc.
HOTH
$1.23
-$0.0198-1.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -23.56% | 42.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -36.72% | 45.85% | |||
| Operating Income | 36.72% | -45.85% | |||
| Income Before Tax | 36.72% | -45.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 36.72% | -45.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 36.72% | -45.86% | |||
| EBIT | 36.72% | -45.85% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 38.89% | 16.20% | |||
| Normalized Basic EPS | 38.90% | 16.20% | |||
| EPS Diluted | 38.89% | 16.20% | |||
| Normalized Diluted EPS | 38.90% | 16.20% | |||
| Average Basic Shares Outstanding | 3.56% | 74.06% | |||
| Average Diluted Shares Outstanding | 3.56% | 74.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||